In addition, in a mouse model of obesity‐induced phenotype, we show that chronic treatment with STA decreased ventricular hypertrophy, a major predictor of cardiovascular events, and improves left ventricular contractility, suggesting a tight association between myocardial PIKfyve activity and cardiac function in the setting of obesity. Here, PIKFYVE is linked to cardiac hypertrophy.